Occult Lung Adenocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
TYLOSIS WITH ESOPHAGEAL CANCER
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
5
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Tumor necrosis factor receptor associated periodic syndrome [TRAPS]
|
disease |
|
Disease or Syndrome
|
6
|
2
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Lymphangitis carcinomatosa
|
disease |
Neoplasms
|
Neoplastic Process
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
NADH cytochrome B5 reductase deficiency
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
7
|
45
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Vascular ring
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mediastinal Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hypertensive end-organ damage
|
disease |
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Lipofibromatosis
|
disease |
Neoplasms
|
Neoplastic Process
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Non-small cell lung cancer recurrent
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
13
|
4
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Donohue Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
15
|
22
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Anaplastic large B-cell lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
17
|
1
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Adenocarcinoma of lung, stage IV
|
disease |
|
Neoplastic Process
|
19
|
6
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2018 |
Advanced Bile Duct Carcinoma
|
disease |
|
Neoplastic Process
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Sarcoma 180
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
20
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Ehrlichiosis
|
disease |
Infections
|
Disease or Syndrome
|
21
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinoma, Giant Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
21
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Psammomatous Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
22
|
|
0.030 |
None |
1.000 |
3 |
|
2016 |
2018 |
Mastitis-metritis-agalactia syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
23
|
3
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Mitochondrial cardiomyopathy
|
disease |
|
Disease or Syndrome
|
23
|
7
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Childhood Epithelioid Hemangioendothelioma
|
disease |
Neoplasms
|
Neoplastic Process
|
26
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Adult Epithelioid Hemangioendothelioma
|
disease |
Neoplasms
|
Neoplastic Process
|
26
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Bronchospasm
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Creatine kinase measurement
|
phenotype |
|
Laboratory Procedure
|
29
|
51
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Epithelioid hemangioendothelioma, malignant
|
disease |
Neoplasms
|
Neoplastic Process
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |